GOGOA BIOENGINEERING at MEDICA 2025: Medical Devices Shaping a More Connected, Efficient and Patient-Centred Healthcare Future

From 17 to 20 November, GOGOA BIOENGINEERING took part in MEDICA 2025 in Düsseldorf – the world’s foremost trade fair for medical technology and healthcare innovation. With more than 5,800 exhibitors from over 70 countries and around 80,000 visitors representing 165 nations, including a remarkably high proportion of senior decision-makers, MEDICA continues to stand as the pre-eminent global rendezvous for those shaping the future of medicine.

For GOGOA BIOENGINEERING, a European leader in exoskeletons and advanced neurorehabilitation technologies, MEDICA is not merely an event: it is the arena in which the next decade of healthcare is outlined, negotiated, and built.

Our presence this year revolved around three key pillars:

1. Showcasing our work within the REVITAL European project at the project’s dedicated stand.

2. Delivering a company pitch at the International Cross-Border Pitching Event @ MEDICA 2025, organised by Life Science Nord, WTSH, IB.SH, IHK zu Lübeck and the Enterprise Europe Network (EEN).

3. Engaging in a highly productive schedule of meetings with hospitals, clinical groups, distributors, innovation clusters and technology providers from across the world.

   
   

MEDICA: Why This Fair Truly Matters

Held annually since the late 1960s, MEDICA has evolved into the most influential showcase of global healthcare innovation. Beyond its extensive exhibition halls, MEDICA features:

• dedicated forums on digital health and clinical software,

• high-profile competitions for healthtech start-ups,

• the German Hospital Conference,

• thematic areas such as the Hospital of the Future and the START-UP PARK.

For hospital directors, clinical chiefs, policymakers, and medical technology investors, MEDICA functions as a strategic observatory – a place to understand which technologies are clinically mature, which partnerships are emerging, and which innovations are set to define tomorrow’s healthcare delivery.

REVITAL: Bringing Advanced Neurorehabilitation and Telecare to Rural Regions

Throughout MEDICA, GOGOA BIOENGINEERING was represented at the stand of the European project REVITAL – Socioeconomic revitalisation of low-density population areas through clinical telecare (S1/4.5/E0037), co-funded by Interreg VI-B Sudoe 2021–2027 through the European Regional Development Fund (ERDF), with a total budget exceeding €2.1 million.

A Strategic Challenge: Ageing, Rurality and Access to Care

REVITAL tackles a common challenge in Southern Europe: ensuring equitable access to specialised care for populations living in sparsely populated, ageing territories such as:

• Castilla y León (Spain)

• Beira Baixa (Portugal)

• The French Basque Country

Here, distances, demographic decline and limited clinical infrastructure often prevent timely access to physiotherapy, neurorehabilitation and multidisciplinary care.

GOGOA BIOENGINEERING’s Contribution to REVITAL

As a medtech manufacturer and neurotechnology innovator, GOGOA BIOENGINEERING contributes:

• its portfolio of clinical exoskeletons – HANK (gait), BELK (knee), and HELK (injury-prevention for professionals),

• its operational experience from our own MOVEX CLINICS in the Basque Country,

• its technological capabilities in tele-rehabilitation, VR therapy and remote patient engagement,

• and its expertise in integrating robotics within multidisciplinary clinical pathways.

The results are already tangible: in the French Basque pilot alone, more than 40 patients have benefited from exoskeleton-assisted therapies guided by physiotherapists, occupational therapists, speech therapists and rehabilitation physicians.

A Transferable Model for Hospitals and Regional Health Systems

REVITAL offers a fully transferable model with clear value for healthcare managers:

1. Hybrid care pathways: combining on-site sessions with remote monitoring and digital rehabilitation.

2. Objective, data-driven rehabilitation: continuous metrics on mobility, effort, adherence and progress.

3. Local socioeconomic impact: creation of new roles, services and territorial healthcare capacities.

For regions facing demographic decline and workforce shortages, REVITAL demonstrates a viable, scalable and clinically robust approach to modernising care delivery.

International Cross-Border Pitching @ MEDICA 2025

Another milestone of our presence at MEDICA was our participation in the International Cross-Border Pitching Event, held on 19 November in the North German Pavilion (Hall 15 / E13).

Organised by Life Science Nord (LSN), WTSH, IB.SH, IHK zu Lübeck, and the Enterprise Europe Network (Hamburg–Schleswig-Holstein), this prestigious event selected companies from across Europe to present in a condensed “2–3 minute, one-slide” format, followed by an exclusive networking reception.

Our pitch focused on:

• our suite of medical exoskeletons,

• our capacity to deploy turnkey neurorehabilitation units,

• and our role as a trusted technological partner within European collaborative projects such as REVITAL.

This opportunity arose through the active support of the Bilbao Chamber of Commerce and our long-standing collaboration with WTSH and the broader Enterprise Europe Network, all of whom play an essential role in helping European SMEs connect, grow, and internationalise.

Enterprise Europe Network & WTSH: Strategic Allies for Innovation and Internationalisation

The Enterprise Europe Network (EEN) is the world’s largest support network for SMEs, composed of more than 600 organisations in over 60 countries, funded by the European Union.

Through WTSH, companies receive:

• expert guidance for internationalisation,

• access to matchmaking platforms and partnership databases,

• opportunities for participation in R&D consortia,

• and support that is entirely free of charge, owing to EU funding.

Figures such as Paula Decker, Foreign Trade Consultant at WTSH, play a pivotal role in connecting enterprises across Europe, enabling companies such as GOGOA BIOENGINEERING to engage with the innovation ecosystem of northern Germany.

What We Learnt at MEDICA 2025: Five Key Trends Shaping Global Healthcare

1. Artificial Intelligence Becoming Tangible Clinical Infrastructure

AI is no longer confined to prototypes: it is now embedded in diagnostic imaging, emergency triage, documentation automation and remote patient monitoring. Hospitals increasingly ask not “What can AI do?” but “How do we integrate it responsibly?”

2. Robotics and Exoskeletons Becoming Standard Medical Equipment

Exoskeletons are now listed alongside treadmills, balance systems and electrotherapy devices. Their clinical acceptance is accelerating rapidly, driven by evidence, ergonomics and workforce sustainability.

3. Telemedicine and Telerehabilitation Completing the “Hospital Without Walls”

Healthcare systems worldwide are shifting towards hybrid models that combine remote follow-up, digital exercise platforms and in-clinic robotics. REVITAL stands as a demonstration of this future made reality, particularly in underserved territories.

4. Workforce Shortages and Ergonomics as Top Priorities

The global shortage of clinicians and the rise of musculoskeletal injuries among healthcare workers are shaping investment decisions. Exoskeletons designed for professional use (such as HELK) are now considered essential tools for workforce sustainability.

5. Europe’s Strategic Drive for Collaborative Healthcare Innovation

Programmes such as Interreg, Horizon Europe and EIT Health are supporting high-impact, multi-country projects aimed at rethinking long-term care, rehabilitation, ageing and digital health. REVITAL fits precisely within this European vision.

A Highly Successful MEDICA – and a Springboard for What Comes Next

Our participation in MEDICA 2025 concluded with:

• an exceptionally active presence at the REVITAL stand,

• a high-profile pitch opening new avenues with university hospitals, clusters and distributors,

• and the confirmation that our strategy – robotics, neurotechnology and integrated rehabilitation services – aligns perfectly with global healthcare trends.

To Our Partners, Clients and Future Collaborators

If you are:

• a director of rehabilitation, neurology, orthopaedics or occupational health,

• a hospital manager or policymaker planning to modernise care pathways,

• or a regional authority exploring solutions for rural or dispersed populations,

we would be delighted to share the insights and solutions presented at MEDICA, and to explore how the REVITAL model and GOGOA BIOENGINEERING technologies can be adapted to your specific context.

At GOGOA BIOENGINEERING we remain committed to a simple principle:

Technology fulfils its purpose only when it reaches the people who need it most – wherever they may live.